High prevalence of the Cys282Tyr HFE mutation facilitates an improved diagnostic service for hereditary haemochromatosis in South Africa

South African Medical Journal

Volumn 89, Issue 3, 1999, Pages 279-282

  De Villiers, J Nico P ^a   Hillerman, Renate ^a   De Jong, Greetje ^a   Langenhoven, Elzet ^a   Marx, Munro P ^a   Kotze, Maritha J ^a   Rossouw, Heleen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; PATIENT REFERRAL; PHLEBOTOMY; RACE DIFFERENCE; RELIABILITY; SOUTH AFRICA;

ADULT; ALLELES; FEMALE; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; SOUTH AFRICA;

EID: 0032929277     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Finch SC, Finch CA. Idiopathic haemochromatosis, an iron storage disease. Medicine 1955; 34: 381-130.
2. Simon M, Le Mignon L, Fauchet R, et al. A study of 609 HLA haplotypes marking for the haemochromatosis gene: (1) mapping the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of haemochromatosis-HLA association. Am J Hum Genet 1987; 41: 89-105.
3. Meyer TE, Ballot D, Bothwell TH, et al. The HLA-linked iron loading gene in an Afrikaner population. J Med Genet 1987; 24: 348-356.
4. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
5. Feder JN, Tsuchihashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts ß2-microglobulin interaction and cell surface expression. J Biol Chem 1997; 272: 14025-14028.
6. Jazwinska EC, Cullen LM, Busfield F, et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14: 249-251.
7. Parkkila S, Waheed A, Britton RS, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997; 94: 13298-13202.
8. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Acad Sci USA 1998; 17:1472-1477.
9. Bacon BR, Sadiq SA. Hereditary hemochromatosis: presentation and diagnosis in the 1990s. Am J Gastroenterol 1997; 92: 784-789.
10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
11. Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary haemochromatosis. Blood Cells Mol Dis 1996; 22:187-194.
12. Gordeuk V, Mukiibi J, Hasstedt SJ, et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med 1992; 326: 95-100.
13. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996; 335: 1779-1805.
14. Beutler E. Significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997; 61: 762-764.
15. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-323.
16. Sampietro M, Piperno A, Lupica L, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 1998; 27:181-184.
17. Hift RJ, Corrigall AV, Meissner PN, Kirsch RE. Significance of HLA mutations in South African patients with porphyria cutanea tarda. Acta Haematol 1997; 98: suppl 1, 112.